Long intergenic non-protein coding RNA 2950 (LINC02950)

Long intergenic non-protein coding RNA 2950 (LINC02950) is a member of the long intergenic non-coding RNA (lincRNA) family, defined as autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes[1][3]. While LINC02950 is annotated in gene databases, its specific biological function, involvement in disease, and roles as a therapeutic target have not been characterized in published literature as of September 2025[1]. In general, lincRNAs are implicated in fine-tuning gene expression, chromatin organization, and transcriptional control through diverse mechanisms, but functional evidence for most individual lincRNAs, including LINC02950, remains limited[3][7]. Key points: - LINC02950 is a non-coding RNA, not a receptor, enzyme, or classical drug target. - There is no evidence that it interacts with drugs or is used for biomarker or therapeutic targeting. - Like other lincRNAs, it may play regulatory roles in gene expression and chromatin but lacks specific functional or clinical annotation.

Other names

LINC02950